{"disease":{"id":"oct-angiography","name":"oct angiography"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03229993","title":"OCT in Borderline Coronary Artery Lesions","phase":"NA","overall_status":"COMPLETED","enrollment_count":220,"lead_sponsor_name":"The First Affiliated Hospital with Nanjing Medical University","has_results":false},{"nct_id":"NCT07036770","title":"Coronary Evaluation And Guided Lesion Exploration Using Photon-counting CT and Intracoronary Imaging Techniques","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Universitaire Ziekenhuizen KU Leuven","has_results":false},{"nct_id":"NCT06978101","title":"Visual Field Changes and OCT Angiographic Chorioretinal Changes in Patients With Primary Open Angle Glaucoma","phase":"","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Assiut University","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}